Examination of Zinc, S-adenosylmethionine, and Combination Therapy Versus Placebo in Alcoholics (ExZACTO)
Alcoholism
About this trial
This is an interventional treatment trial for Alcoholism focused on measuring alcoholism, lung health, pulmonary, macrophage, zinc, SAMe, S-adenosylmethionine, alveolar
Eligibility Criteria
Inclusion Criteria:
- Age 18-60 years
- Active alcohol use disorder
Exclusion Criteria:
- Any active and uncontrolled medical problem(s)
- Known zinc deficiency
- Primary substance of abuse something other than alcohol
- Current abnormal chest x-ray
- HIV-positive
- Any disorder of blood coagulation
Currently on medical treatment with anti-coagulants, including:
- warfarin
- heparin
- direct thrombin inhibitors
- anti-platelet agents (other than Aspirin)
- Daily use of vitamins or other nutritional supplements (unless taking as treatment for alcohol use disorder)
- Renal impairment (GFR < 60)
- Active bipolar disorder
- Active Parkinson's disease
- Current pregnancy
- Contraindication to treatment with zinc or S-adenosylmethionine
- Inability to give informed consent (i.e., limited cognitive capacity)
- Non-English speaking
Sites / Locations
- Atlanta VA Medical and Rehab Center, Decatur, GA
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Placebo Comparator
Active Comparator
Active Comparator
Active Comparator
Placebo zinc and placebo SAMe
Active zinc and placebo SAMe
Placebo zinc and active SAMe
Active zinc and active SAMe
Placebo tablet of zinc sulfate once daily and placebo tablet of s-adenosylmethionine twice daily
Zinc sulfate 220 mg once daily and placebo tablet of s-adenosylmethionine twice daily
Placebo tablet of zinc sulfate once daily and s-adenosylmethionine 400 mg twice daily
Zinc sulfate 220 mg once daily and s-adenosylmethionine 400 mg twice daily